Association between interleukin-22 genetic polymorphisms and bladder cancer risk

about

A catch-22: Interleukin-22 and cancer.

P2860

Q48231667-BD348479-00E4-4FC5-8C63-52816F3DE06D

P2860

Association between interleukin-22 genetic polymorphisms and bladder cancer risk

Item

http://www.wikidata.org/entity/Q36150520

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Association between interleukin-22 genetic polymorphisms and bladder cancer risk

@ast

Association between interleukin-22 genetic polymorphisms and bladder cancer risk

@en

type

Item

label

Association between interleukin-22 genetic polymorphisms and bladder cancer risk

@ast

Association between interleukin-22 genetic polymorphisms and bladder cancer risk

@en

prefLabel

Association between interleukin-22 genetic polymorphisms and bladder cancer risk

@ast

Association between interleukin-22 genetic polymorphisms and bladder cancer risk

@en

P1476

Association between interleukin-22 genetic polymorphisms and bladder cancer risk

@en

P2093

JiaJi Liu

http://www.w3.org/2001/XMLSchema#string

Tao Zhao

http://www.w3.org/2001/XMLSchema#string

XiaoHou Wu

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2014

Common polymorphisms in the interleukin-22 gene are not associated with chronic plaque psoriasis

IL-22 increases the innate immunity of tissues

Interleukin-22 genetic polymorphisms and risk of colon cancer

A genome-wide association study of bladder cancer identifies a new susceptibility locus within SLC14A1, a urea transporter gene on chromosome 18q12.3

A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci

A genome-wide association study identifies a locus on chromosome 14q21 as a predictor of leukocyte telomere length and as a marker of susceptibility for bladder cancer

Complex association between ERCC2 gene polymorphisms, gender, smoking and the susceptibility to bladder cancer: a meta-analysis.

Relationships between CYP1A1 genetic polymorphisms and bladder cancer risk: a meta-analysis.

European genome-wide association study identifies SLC14A1 as a new urinary bladder cancer susceptibility gene.

P304

686-690

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.6061/CLINICS/2015(10)05

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26598081

http://www.w3.org/2001/XMLSchema#string

P932

4602377

http://www.w3.org/2001/XMLSchema#string

Association between interleukin-22 genetic polymorphisms and bladder cancer risk

about

P2860

P2860

Association between interleukin-22 genetic polymorphisms and bladder cancer risk

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932